ClinicalTrials.gov
ClinicalTrials.gov Menu

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00226330
Recruitment Status : Terminated (The development program has been terminated)
First Posted : September 27, 2005
Last Update Posted : November 19, 2010
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2006
  Actual Study Completion Date : December 2006